Management of multifocal and metastatic retroperitoneal sarcoma: an updated consensus approach from the transatlantic australasian retroperitoneal sarcoma working group (TARPSWG)
Chiara Fabbroni(Fondazione IRCCS Istituto Nazionale dei Tumori), William W. Tseng(Brigham and Women's Hospital), Dimitri Tzanis(Université Paris Cité), Dario Callegaro(Fondazione IRCCS Istituto Nazionale dei Tumori), Elena Di Blasi(Fondazione IRCCS Istituto Nazionale dei Tumori), Mai‐Kim Gervais(Hôpital Maisonneuve-Rosemont), David J. Konieczkowski(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Toufik Bouhadiba(Institut Curie), S. Bonvalot(Institut Curie), Ferdinando Cananzi(Humanitas University), Rebecca A. Gladdy(Princess Margaret Cancer Centre), Abdulazeez Salawu(Princess Margaret Cancer Centre), Kyo Won Lee(Samsung Medical Center), John E. Mullinax(Moffitt Cancer Center), Valerie P. Grignol(Ohio State University Hospital), Chandrajit P. Raut(Dana-Farber Cancer Institute), Roberta Sanfilippo(Fondazione IRCCS Istituto Nazionale dei Tumori), Silvia Stacchiotti(Fondazione IRCCS Istituto Nazionale dei Tumori), Markus Albertsmeier(LMU Klinikum), Susie Bae(Peter MacCallum Cancer Centre), Jeffrey M. Farma(Fox Chase Cancer Center), Michelle Wilkinson(Royal Marsden Hospital), Elisabetta Pennacchioli(European Institute of Oncology), Piotr Rutkowski(The Maria Sklodowska-Curie National Research Institute of Oncology), Christina L. Roland(The University of Texas MD Anderson Cancer Center), Carol J. Swallow(Princess Margaret Cancer Centre), Shreyaskumar Patel(The University of Texas MD Anderson Cancer Center), Edward.W. Johnston(Royal Marsden NHS Foundation Trust), Margaret von Mehren(Fox Chase Cancer Center), Dirk C. Strauss(Royal Marsden NHS Foundation Trust), Piergiorgio Solli(Fondazione IRCCS Istituto Nazionale dei Tumori), Yvonne M. Schrage(Dutch Cancer Society), Jiping Wang(Dana-Farber Cancer Institute), Mateusz Spalek(The Maria Sklodowska-Curie National Research Institute of Oncology), Marco Fiore(Fondazione IRCCS Istituto Nazionale dei Tumori), Alessandro Gronchi(Fondazione IRCCS Istituto Nazionale dei Tumori), Lee Cranmer(City Of Hope National Medical Center), Winan. J. Van Houdt(Dutch Cancer Society), Teresa Y. Lee(Fox Chase Cancer Center), Carolyn Nessim(Ottawa Hospital), Andrew J. Wagner(Dana-Farber Cancer Institute), David E. Gyorki(Peter MacCallum Cancer Centre), Samuel J. Ford(University of Birmingham), Andrea Napolitano(National Health Service), Jenny Sherriff(Queen Elizabeth Hospital Birmingham), Jason K. Sicklick(University of California San Diego)
Cited by 0
Related Papers
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
|Journal of the National Comprehensive Cancer Network|2010|1.2k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
|Nature Medicine|2019|726
Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services
|British journal of surgery|2020|719